120 filings
Page 3 of 6
8-K
kl3i70
18 May 21
Other Events
3:09pm
8-K
j6tjjnqgp8
17 May 21
Submission of Matters to a Vote of Security Holders
6:08am
8-K
xj6s n9t1snmsp5f8r
11 May 21
Other Events
8:34am
8-K
jq7ht
10 May 21
Larimar Therapeutics Reports First Quarter 2021 Operating and Financial Results
4:15pm
8-K/A
er45 hc7s91w4ke7u2kj
4 Mar 21
Unaudited Pro Forma Combined Financial Statements
5:16pm
8-K
dyfccq63qo7n4 q49f
4 Mar 21
Larimar Therapeutics Reports Fourth Quarter and Full Year 2020 Operating and Financial Results
7:30am
8-K
mrvtd0aw3s djo0r45
8 Dec 20
Regulation FD Disclosure
7:40am
8-K/A
wibzpjhp6 a3
12 Nov 20
Unaudited Pro Forma Combined Financial Statements
4:51pm
8-K
yip2xh6p 3jc6z7
10 Nov 20
Larimar Therapeutics Reports Third Quarter 2020 Operating and Financial Results
4:23pm
8-K
6hkjvwzrp
30 Oct 20
Entry into a Material Definitive Agreement
5:02pm
8-K/A
vb3a qgbo
29 Sep 20
Departure of Directors or Certain Officers
4:39pm
8-K
j0yjnrwryg4tyv1ygc
29 Sep 20
Departure of Directors or Certain Officers
7:06am
8-K/A
gdl9td5syz
14 Aug 20
Unaudited Pro Forma Combined Financial Statements
4:56pm
8-K
p29zre02fmnmy
11 Aug 20
Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
7:38am
8-K
msire lpk3sjmt38e4mo
6 Aug 20
Departure of Directors or Certain Officers
9:00am
8-K/A
0c30kf1
26 Jun 20
Other Events
5:08pm
8-K
ips8urcx
3 Jun 20
Regulation FD Disclosure
12:00am
8-K
keqgmmi6
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
2ez3uts42e424
24 Apr 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:01pm
8-K
tc3qxn1
9 Mar 20
Entry into a Material Definitive Agreement
12:00am